Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company's operations include facilities in Boston, MA, and in Gainesville, FL.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/22/13 | $32,000,000 | Series A |
Hatteras Venture Partners MPM Capital Osage University Partners | undisclosed |
